Cerity Partners’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17M Buy
325,894
+35,001
+12% +$1.82M 0.03% 395
2025
Q1
$18.6M Sell
290,893
-43,959
-13% -$2.81M 0.04% 349
2024
Q4
$16.4M Buy
334,852
+35,064
+12% +$1.71M 0.04% 363
2024
Q3
$17.2M Buy
299,788
+8,732
+3% +$500K 0.04% 352
2024
Q2
$15.2M Sell
291,056
-4,485
-2% -$235K 0.04% 321
2024
Q1
$12M Buy
295,541
+26,023
+10% +$1.06M 0.03% 402
2023
Q4
$9.96M Buy
269,518
+16,286
+6% +$602K 0.03% 374
2023
Q3
$9.67M Sell
253,232
-4,889
-2% -$187K 0.05% 298
2023
Q2
$9.31M Buy
258,121
+2,533
+1% +$91.4K 0.04% 355
2023
Q1
$9.76M Sell
255,588
-3,692
-1% -$141K 0.02% 359
2022
Q4
$14.8M Buy
259,280
+252,580
+3,770% +$14.4M 0.09% 203
2022
Q3
$265K Buy
6,700
+747
+13% +$29.5K ﹤0.01% 951
2022
Q2
$262K Buy
+5,953
New +$262K ﹤0.01% 961